[1]
WAYHS, C.A. and Von DIEMEN, T. 2024. Pharmacovigilance Program impact on notifications of adverse reactions to antineoplastic drug in a university hospital. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde. 15, 2 (Jun. 2024), e1118. DOI:https://doi.org/10.30968/rbfhss.2024.152.1118.